The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSunrise Res Regulatory News (SRES)

Share Price Information for Sunrise Res (SRES)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0475
Bid: 0.045
Ask: 0.05
Change: 0.00 (0.00%)
Spread: 0.005 (11.111%)
Open: 0.0475
High: 0.0475
Low: 0.0475
Prev. Close: 0.0475
SRES Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Additional £200,000 Investment

5 Jun 2023 07:00

RNS Number : 5676B
Sunrise Resources Plc
05 June 2023
 
5 June 2023

 

SUNRISE RESOURCES PLC

(the "Company")

 

Additional £200,000 Investment

 

Sunrise Resources plc (AIM: SRES), the AIM-traded company focusing on the development of its three key Nevada based industrial mineral projects, wishes to announce that the Company is expected to receive within the next week the second investment, subject to amended terms as set out below, of £200,000 from Towards Net Zero, LLC (the "Investor"), a U.S.-based institutional investor focused on the green economy, through the issuance of a convertible security with a face value £200,000 to the Investor (the "Second Convertible Security"), pursuant to the investment agreement with the Investor disclosed to the market on 30 November 2022 (the "November Announcement").

The Second Convertible Security will have a term of 24 months. The Second Convertible Security will (subject to the satisfaction of certain conditions) be convertible into Ordinary Shares of the Company, in whole or in part, at the option of Investor. The Investor has agreed to modify the terms of the Second Convertible Security so that the Second Convertible Security will not be subject to quarterly repayments set out in the November Announcement, to assist the Company's capital management. The Conversion Price for the Second Convertible Security will be equal to the Market Price (being 98% of the average of five daily volume-weighted average prices of the shares on AIM during a specified period preceding the relevant conversion, rounded down to the next one hundredth of a pence as set out in the November Announcement) without regard to the application of the Floor Price set out in the November Announcement. Furthermore, the definition of the Floor Price in the November Announcement has been amended to be the lesser of 0.1p or the par value of the Company's Ordinary Shares, currently 0.1p. The Company may at any time, on thirty days' notice, redeem the outstanding face value of each convertible security for cash, with a 10% premium, subject to the Investor's rights to hold back up to one third of the outstanding face value from redemption or convert the outstanding convertible security. At maturity, the Company may redeem the outstanding face value of the convertible securities for cash (with no premium).

As noted in the November Announcement, the Investor has agreed to certain, substantial, limitations on its ability to dispose of the shares following a conversion of a convertible security and is contractually precluded from shorting the Company's shares.

 

A summary of the remainder of the terms of the investment agreement is set out in the November Announcement and this announcement should be read in conjunction with the November Announcement.

 

Further information:

 

Sunrise Resources plc

Patrick Cheetham, Executive Chairman

Tel: +44 (0)1625 838 884

 

Beaumont Cornish Limited

Nominated Adviser

James Biddle/Roland Cornish

Tel: +44 (0)207 628 3396

 

Peterhouse Capital Limited

Broker

Lucy Williams/Duncan Vasey

 

Tel: +44 (0)207 469 0930

 

 

 

Shares in the Company trade on AIM. EPIC: "SRES".

Website: www.sunriseresourcesplc.com

 

 

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ('MAR'). Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDKZGGVLZLGFZM
Date   Source Headline
2nd Apr 20247:00 amRNSSALE OF DIATOMITE CLAIMS
28th Mar 20247:00 amRNSTotal Voting Rights
7th Mar 202411:20 amRNSDIRECTOR DEALING
5th Mar 20247:00 amRNSIssue of Shares following Conversion & TVR
29th Feb 202410:11 amRNSTotal Voting Rights
23rd Feb 202412:27 pmRNSDIRECTOR DEALING, ISSUE OF EQUITY & TVR
23rd Feb 202411:35 amRNSVoting at AGM
22nd Feb 202412:32 pmRNSResult of AGM
26th Jan 202410:00 amRNSANNUAL REPORT AND NOTICE OF 2024 AGM
24th Jan 20247:00 amRNSFinal Results
18th Jan 20247:00 amRNSPioche Sepiolite Project
27th Dec 202310:31 amRNSPioche Sepiolite Project
4th Dec 20231:55 pmRNSGarfield Royalty Interest
1st Dec 20237:00 amRNSInvestor Presentation
22nd Nov 20239:51 amRNSResult of Meeting
7th Nov 20237:00 amRNSProposed Sub-Division of Share Capital
31st Oct 20237:00 amRNSReese Ridge Zinc-Lead-Silver (-Gallium) Project
27th Sep 20237:00 amRNSPioche Project Update
15th Sep 20237:00 amRNSMarket Study and Pozzolan Project Update
31st Aug 20236:09 pmRNSTotal Voting Rights
11th Aug 202312:51 pmRNSIssue of Shares following Conversion & TVR
11th Aug 202312:45 pmRNSISSUE OF WARRANTS
3rd Aug 20234:20 pmRNSHolding(s) in Company
25th Jul 20237:00 amRNSPioche Resource Drilling Programme in Progress
4th Jul 202312:38 pmRNSIssue of Equity & TVR
29th Jun 20237:00 amRNSReese Ridge Project Update
12th Jun 20237:00 amRNSPioche Project Update
8th Jun 202312:16 pmRNSDIRECTOR DEALING, ISSUE OF EQUITY & TVR
5th Jun 20237:00 amRNSAdditional £200,000 Investment
31st May 202311:46 amRNSHalf-year Report
23rd May 20237:00 amRNSNatural Pozzolan Association Symposium
4th May 20233:34 pmRNSTotal Voting Rights
26th Apr 20237:00 amRNSPioche Project Update
14th Apr 202311:52 amRNSHolding(s) in Company
6th Apr 202312:38 pmRNSIssue of Equity & TVR
24th Mar 20237:00 amRNSISSUE OF WARRANTS
15th Mar 20237:00 amRNSNEW MINING CLAIMS: REESE RIDGE PROJECT
17th Feb 202311:57 amRNSResult of AGM
17th Feb 20237:00 amRNSAGM Chairman’s Statement
17th Jan 20239:19 amRNSDIRECTOR DEALING, ISSUE OF EQUITY & TVR
9th Jan 20237:00 amRNSPioche claims update
22nd Dec 20227:00 amRNSAnnual Report and Notice of AGM
21st Dec 20227:00 amRNSTolsa maintain option to acquire Sepiolite Project
13th Dec 20229:23 amRNSAudited Results for the year to 30 September 2022
7th Dec 20221:54 pmRNSIssue of Convertible Security
30th Nov 20227:00 amRNS£480,000 Investment, Issue of Equity & TVR
22nd Nov 202211:55 amRNSHolding(s) in Company
25th Oct 20227:00 amRNSUpdate - Pioche Sepiolite Project
12th Oct 20227:00 amRNSBulk Sampling - Hazen Pozzolan Project, Nevada
2nd Sep 20227:00 amRNSUpdate - Pioche Sepiolite Project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.